| Product Code: ETC12463471 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Imatinib Drug Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Imatinib Drug Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Imatinib Drug Market - Industry Life Cycle |
3.4 Israel Imatinib Drug Market - Porter's Five Forces |
3.5 Israel Imatinib Drug Market Revenues & Volume Share, By Drug Form, 2021 & 2031F |
3.6 Israel Imatinib Drug Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Israel Imatinib Drug Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Israel Imatinib Drug Market Revenues & Volume Share, By Sales Channel, 2021 & 2031F |
3.9 Israel Imatinib Drug Market Revenues & Volume Share, By Mode of Administration, 2021 & 2031F |
4 Israel Imatinib Drug Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Israel |
4.2.2 Growing awareness about targeted cancer therapies |
4.2.3 Favorable government regulations supporting access to innovative drugs |
4.3 Market Restraints |
4.3.1 High cost of imatinib therapy |
4.3.2 Competition from generic imatinib drugs |
4.3.3 Potential side effects and safety concerns associated with imatinib |
5 Israel Imatinib Drug Market Trends |
6 Israel Imatinib Drug Market, By Types |
6.1 Israel Imatinib Drug Market, By Drug Form |
6.1.1 Overview and Analysis |
6.1.2 Israel Imatinib Drug Market Revenues & Volume, By Drug Form, 2021 - 2031F |
6.1.3 Israel Imatinib Drug Market Revenues & Volume, By Tablets, 2021 - 2031F |
6.1.4 Israel Imatinib Drug Market Revenues & Volume, By Capsules, 2021 - 2031F |
6.1.5 Israel Imatinib Drug Market Revenues & Volume, By Powder Form, 2021 - 2031F |
6.1.6 Israel Imatinib Drug Market Revenues & Volume, By Liquid Form, 2021 - 2031F |
6.1.7 Israel Imatinib Drug Market Revenues & Volume, By Extended Release Tablets, 2021 - 2031F |
6.2 Israel Imatinib Drug Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Israel Imatinib Drug Market Revenues & Volume, By Leukemia Treatment, 2021 - 2031F |
6.2.3 Israel Imatinib Drug Market Revenues & Volume, By Gastrointestinal Stromal Tumors, 2021 - 2031F |
6.2.4 Israel Imatinib Drug Market Revenues & Volume, By Chronic Myeloid Leukemia, 2021 - 2031F |
6.2.5 Israel Imatinib Drug Market Revenues & Volume, By Breast Cancer Treatment, 2021 - 2031F |
6.2.6 Israel Imatinib Drug Market Revenues & Volume, By Rare Tumor Management, 2021 - 2031F |
6.3 Israel Imatinib Drug Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Israel Imatinib Drug Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 Israel Imatinib Drug Market Revenues & Volume, By Cancer Research Centers, 2021 - 2031F |
6.3.4 Israel Imatinib Drug Market Revenues & Volume, By Specialty Clinics, 2021 - 2031F |
6.3.5 Israel Imatinib Drug Market Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031F |
6.3.6 Israel Imatinib Drug Market Revenues & Volume, By Government Healthcare Units, 2021 - 2031F |
6.4 Israel Imatinib Drug Market, By Sales Channel |
6.4.1 Overview and Analysis |
6.4.2 Israel Imatinib Drug Market Revenues & Volume, By Direct Procurement, 2021 - 2031F |
6.4.3 Israel Imatinib Drug Market Revenues & Volume, By Distributors, 2021 - 2031F |
6.4.4 Israel Imatinib Drug Market Revenues & Volume, By Online Pharmacies, 2021 - 2031F |
6.4.5 Israel Imatinib Drug Market Revenues & Volume, By Hospital Pharmacies, 2021 - 2031F |
6.4.6 Israel Imatinib Drug Market Revenues & Volume, By Retail Pharmacies, 2021 - 2031F |
6.5 Israel Imatinib Drug Market, By Mode of Administration |
6.5.1 Overview and Analysis |
6.5.2 Israel Imatinib Drug Market Revenues & Volume, By Oral Administration, 2021 - 2031F |
6.5.3 Israel Imatinib Drug Market Revenues & Volume, By Injection Therapy, 2021 - 2031F |
6.5.4 Israel Imatinib Drug Market Revenues & Volume, By Infusion Therapy, 2021 - 2031F |
6.5.5 Israel Imatinib Drug Market Revenues & Volume, By Combination Therapy, 2021 - 2031F |
6.5.6 Israel Imatinib Drug Market Revenues & Volume, By Targeted Therapy, 2021 - 2031F |
7 Israel Imatinib Drug Market Import-Export Trade Statistics |
7.1 Israel Imatinib Drug Market Export to Major Countries |
7.2 Israel Imatinib Drug Market Imports from Major Countries |
8 Israel Imatinib Drug Market Key Performance Indicators |
8.1 Patient adherence rate to imatinib therapy |
8.2 Number of oncology clinics offering imatinib treatment |
8.3 Rate of new clinical trials testing imatinib for different cancer types |
9 Israel Imatinib Drug Market - Opportunity Assessment |
9.1 Israel Imatinib Drug Market Opportunity Assessment, By Drug Form, 2021 & 2031F |
9.2 Israel Imatinib Drug Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Israel Imatinib Drug Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Israel Imatinib Drug Market Opportunity Assessment, By Sales Channel, 2021 & 2031F |
9.5 Israel Imatinib Drug Market Opportunity Assessment, By Mode of Administration, 2021 & 2031F |
10 Israel Imatinib Drug Market - Competitive Landscape |
10.1 Israel Imatinib Drug Market Revenue Share, By Companies, 2024 |
10.2 Israel Imatinib Drug Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here